Ann: USCOM validated in pregnancy , page-5

G3S, you seem disillusioned with the company's performance / announcements... seems like you paid too much too soon. i'm only a recent holder, did some research on the back of the spacelabs deal and placement and frankly saw enormous potential. the story with many embryonic and disruptive technology companies is that they take time to penetrate the market and accumulate goodwill. if you ask me UCM has just started in earnest (forget about the local market which is peanuts). i'm comfortable with my investment at this stage but will be concerned if sales do not dramatically improve this year.